Investment ThemesDetailed Quotes
Weight Loss Drugs Watchlist

GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.

  • 1691.998
  • +26.240+1.58%
Close Feb 25 16:00 ET
1715.520High1679.987Low
Constituent Stocks: 7Top Rising: LLY+2.31%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
LLYEli Lilly and Co
901.80020.400+2.31%5.11M4.61B890.740881.400912.000890.740855.06B854.26B948.17M947.29M+5.20%+3.97%+11.78%+19.65%-5.74%+17.59%+17.02%0.58%0.54%77.0177.012.41%Drug Manufacturers - General
AMGNAmgen
315.6305.910+1.91%4.37M1.38B311.800309.720318.300310.300169.56B169.13B537.20M535.84M+7.80%+7.94%+12.45%+8.23%-3.92%+13.58%+22.08%2.85%0.82%41.7541.752.58%Drug Manufacturers - General
NVONovo-Nordisk A/S
90.9500.360+0.40%11.47M1.05B92.28090.59093.80089.000403.88B290.12B4.44B3.19B+10.47%+8.39%+3.93%-13.02%-34.64%-25.54%+5.73%1.51%0.36%28.5028.505.30%Drug Manufacturers - General
PFEPfizer
26.7400.090+0.34%43.56M1.17B26.72026.65027.03026.540151.54B151.31B5.67B5.66B+4.62%+3.36%-0.45%+3.87%-4.84%+4.55%+2.46%6.28%0.77%18.9618.961.84%Drug Manufacturers - General
GPCRStructure Therapeutics
21.0900.060+0.29%611.65K12.70M21.02021.03021.50020.1201.21B1.08B57.26M51.21M-7.17%-13.17%-25.74%-37.99%-44.69%-48.60%-22.23%--1.19%LossLoss6.56%Biotechnology
VKTXViking Therapeutics
28.320-0.880-3.01%5.84M165.02M29.50029.20029.60027.5003.16B3.09B111.57M109.09M-3.21%-6.13%-15.36%-45.53%-55.83%-26.40%-29.62%--5.36%LossLoss7.19%Biotechnology
ALTAltimmune
5.910-0.200-3.27%2.37M14.14M6.2006.1106.2305.800420.35M416.40M71.12M70.46M-8.80%-10.59%-15.57%-31.04%-11.79%-47.79%-18.03%--3.36%LossLoss7.03%Biotechnology

News

Comments

Read more